Toolbox
Creating a start-up: Minimising failure rates
This presentation provides an overview of the elements to consider while a start-up project moves towards incorporation in order to minimize the risk of failure.
This presentation provides an overview of the elements to consider while a start-up project moves towards incorporation in order to minimize the risk of failure.
This presentation provides an overview of the elements generally considered by each of the parties involved in the discussion on the relative value of the transferred intellectual property and know how at the time of the incorporation of a start-up company.
This document is interesting reference document for those involved in negotiating and drafting agreements governing collaborations between research institutes.
More and more innovation is driven by research collaborations between different entities. Within the context of globalized economy, these research and innovation collaborations are becoming increasingly internationalised.
Though the scale and substance of collaborations varies, a basic understanding of intellectual property rights (IPR) within the Chinese context may help to maximize the success of joint cooperation.
Samples of human biological material are used for many purposes and are of increasing importance as the funders of research, whether public, charitable or commercial, prioritise areas which rely upon access to human biological samples.
PROvendis has its origins in the innovation consulting firm Zenit GmbH. Founded in 1984, ZENIT is a Public Private Partnership owned by the State of North Rhine- Westphalia, a consortium of banks and an association comprising some 180 enterprises.
The IOCB Technology Transfer Office s.r.o (IOCB TTO) is a wholly-owned subsidiary company of IOCB and a leading technology transfer office in the Czech Republic in the field of pharmaceutical, chemical and biotechnology research and development.
Founded in 2001 as a wholly-owned subsidiary of the LifeScience Foundation, Ascenion is a technology transfer company focusing on the field of life sciences. It currently serves a total of 23 research institutes and university hospitals all over Germany.
In order to assist its researchers in providing this information, KU Leuven Research & Development (technology transfer office of KU Leuven) has developed a mandatory Patent Inventor Form.
This document starts from the observation that in tandem with rapid advances in biotechnology research having valuable applications for use in healthcare the Canadian technology transfer activity has grown significantly.
While the IP Office recognizes that the specifics of any start-up company development may be unique, it has identified a number of common elements and the IP Office has developed standard mechanisms and support structures to assist with this process.
Join our newsletter and get the latest news